Ameritas Investment Partners, Inc. - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$8,000
+33.3%
1,7600.0%0.00%
Q4 2018$6,000
-66.7%
1,7600.0%0.00%
-100.0%
Q3 2018$18,000
+38.5%
1,7600.0%0.00%0.0%
Q2 2018$13,000
+18.2%
1,7600.0%0.00%0.0%
Q1 2018$11,000
-35.3%
1,7600.0%0.00%0.0%
Q4 2017$17,000
+6.2%
1,7600.0%0.00%0.0%
Q3 2017$16,000
-27.3%
1,7600.0%0.00%0.0%
Q2 2017$22,000
+22.2%
1,7600.0%0.00%0.0%
Q1 2017$18,0001,7600.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2017
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders